Keyword: fast track status
News
07.01.2016
- Germany’s Merck KGaA and Pfizer of the US are collaborating with US biopharmaceutical company Syndax to evaluate a combination of avelumab and entinostat to treat advanced ovarian...
News
08.10.2015
- After previously receiving Orphan Drug status for avelumab, an investigational fully human anti-PD-L1 IgG1 monoclonal antibody to treat the rare and aggressive skin cancer Merkel...
